EMA: PRAC RECOMMENDED CHANGE TO PRODUCT INFORMATION FOR VAXZEVRIA, COVID-19 VACCINE JANSSEN TO INCLUDE WARNING TO RAISE AWARENESS OF VERY RARE CASES OF TM FOLLOWING VACCINATION